We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$110B
AUM Growth
+$10.8B
Cap. Flow
+$4.52B
Cap. Flow %
4.11%
Top 10 Hldgs %
23.63%
Holding
4,320
New
332
Increased
2,194
Reduced
1,423
Closed
241

Sector Composition

Rank Sector Weight
1 Technology 14.49%
2 Financials 8.91%
3 Healthcare 8.14%
4 Industrials 6.57%
5 Consumer Discretionary 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POWW icon
3901
CALL
Outdoor Holding Co
POWW
$297M
$45K ﹤0.01%
+60,000
New +$427K
WATT icon
3902
Energous
WATT
$102M
$45K ﹤0.01%
26
+8
+44% +$14.5K
TTOO
3903
DELISTED
T2 Biosystems, Inc
TTOO
$44K ﹤0.01%
7
+1
+17% +$6.46K
USB icon
3904
CALL
US Bancorp
USB
$100B
$43K ﹤0.01%
138,500
+123,500
+823% +$7.25M
WTFC icon
3905
CALL
Wintrust Financial
WTFC
$10.7B
$43K ﹤0.01%
+28,600
New +$2.23M
APD icon
3906
CALL
Air Products & Chemicals
APD
$68.6B
$42K ﹤0.01%
31,100
-9,300
-23% -$2.73M
PLTR icon
3907
CALL
Palantir
PLTR
$421B
$42K ﹤0.01%
+59,600
New +$1.38M
PLUR icon
3908
Pluri
PLUR
$19.9M
$41K ﹤0.01%
1,282
BBIG
3909
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$41K ﹤0.01%
+772
New +$33.2K
CTXR icon
3910
Citius Pharmaceuticals
CTXR
$18.6M
$40K ﹤0.01%
+460
New +$27.6K
MDT icon
3911
CALL
Medtronic
MDT
$114B
$40K ﹤0.01%
42,800
-16,900
-28% -$2.12M
MLSS icon
3912
Milestone Scientific
MLSS
$42M
$39K ﹤0.01%
+16,000
New +$38.8K
PII icon
3913
CALL
Polaris
PII
$3.97B
$39K ﹤0.01%
15,300
-300
-2% -$40.7K
SBSW icon
3914
CALL
Sibanye-Stillwater
SBSW
$7.55B
$39K ﹤0.01%
+19,900
New +$369K
WFC icon
3915
CALL
Wells Fargo
WFC
$265B
$39K ﹤0.01%
82,000
+43,900
+115% +$1.96M
GSK icon
3916
CALL
GSK
GSK
$104B
$38K ﹤0.01%
76,000
+62,800
+476% +$3.02M
LOB icon
3917
CALL
Live Oak Bancshares
LOB
$1.95B
$38K ﹤0.01%
35,900
+5,100
+17% +$320K
LBAI
3918
CALL
DELISTED
Lakeland Bancorp Inc
LBAI
$38K ﹤0.01%
63,200
+200
+0.3% +$3.63K
ABBV icon
3919
CALL
AbbVie
ABBV
$438B
$37K ﹤0.01%
48,600
+38,400
+376% +$4.32M
HURA
3920
TuHURA Biosciences
HURA
$137M
$36K ﹤0.01%
9
AGRX
3921
DELISTED
Agile Therapeutics
AGRX
$36K ﹤0.01%
13
NAT icon
3922
Nordic American Tanker
NAT
$1.33B
$34K ﹤0.01%
10,390
-4,948
-32% -$16.7K
RF icon
3923
CALL
Regions Financial
RF
$26.8B
$34K ﹤0.01%
20,500
-3,500
-15% -$75.7K
CWBR
3924
DELISTED
CohBar, Inc. Common Stock
CWBR
$34K ﹤0.01%
814
+76
+10% +$2.98K
QCOM icon
3925
CALL
Qualcomm
QCOM
$170B
$33K ﹤0.01%
21,400
+2,000
+10% +$270K

Similar funds

Raymond James & Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Raymond James & Associates held 4,320 positions worth $110B, up 11% from $99.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates deployed $4.52B of net new capital in Q2 2021, opening 332 new positions and adding to 2,194 existing holdings. Its largest new stake was Just Eat Takeaway.com N.V. American Depositary Shares: 583,879 shares worth $10.7M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $175M trimmed.

  • Raymond James & Associates's largest Q2 2021 buy was Just Eat Takeaway.com N.V. American Depositary Shares: 583,879 shares worth $10.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2021, an estimated $290M increase.
  • Raymond James & Associates's biggest Q2 2021 reduction was Amgen, cutting an estimated $175M.
  • Raymond James & Associates fully exited FLIR Systems, Inc. (DE) Common Stock in Q2 2021, selling an estimated $19.1M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $110B portfolio in Q2 2021.
  • Raymond James & Associates opened 332 new positions and closed 241 in Q2 2021.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $110B.

Based on Raymond James & Associates's 13F filing for Q2 2021, filed 11 Aug 2021.